We now have preventative therapies for women at high risk for EOP with delivery at <33 wks' gestation (aspirin) and sPTB at ≤33 wks' gestation (+/- preterm premature rupture of membranes (PPROMs)) (docosahexaenoic acid (DHA). This evidence concerns the gene SPTB and Premature rupture of membranes.